Imaging and staging of head and neck cancer using a low pH In-111-bleomycin complex

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 5, 1996, Pages 311-321

  Kairemo, K J A ^a   Ramsay, H A ^a   Paavonen, T ^a   Bondestam, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bleomycin; Head and neck neoplasm; Indium radioisotopes; Radionuclide imaging; Tumour targeting

Indexed keywords

BLEOMYCIN IN 111; RADIOISOTOPE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PH; PRIORITY JOURNAL; SCINTISCANNING;

EID: 0030249754     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(96)00005-X     Document Type: Article

References (43)

1. 1. Umezawa H, Maeda K, Takeuchi K, Okami Y. New antibiotics, bleomycin A and B. J Antibiot (A) 1966, 19, 200-209.
2. 2. Umezawa H, Ishizuka M, Maeda K, Takeuchi T. Studies on bleomycin. Cancer 1967, 20, 891-895.
3. 3. Renault H, Henry R, Rapin J, Hegesippe M. Chelation de cations radiactifs par un polypeptide: la bleomycine. In: Radiopharmaceuticals and Labelled Compounds, Vol. II, IAEA, Vienna, 1973, 195-202.
4. 4. Nieweg OE, Piers DA, Beekhuis H, Sluiter HJ, Wal AM van der, Woldring MG. 57Co-bleomycin scintigraphy for the staging of lung cancer. Cancer 1989, 63, 1119-1122.
5. 5. Frederiksen PB, Christensen JB, Veilstedt H, Rasmussen JW, Pedersen B, Edeling C-J. 57Co-bleomycin scintigraphy for the preoperative detection and staging of lung tumors. Nucl Med 1988, 27, 79-82.
6. 6. Even-Sapir E, Bettman L, Iosilevsky G, et al. SPECT quantitation of cobalt-57-bleomycin to predict treatment response and outcome of patients with lung cancer. J Nucl Med 1994, 35, 1129-1133.
7. 7. Thakur ML, Merrick MV, Gunasekera SW. Some pharmacological aspects of a new radiopharmaceutical, 111In-bleomycin. In: Radiopharmaceuticals and Labelled Compounds, Vol. II, IAEA, Vienna, 1973, 183-193.
8. 8. Hou D-Y, Hoch H, Johnston GS, et al. A new 111-In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice. J Surg Oncol 1984, 25, 168-175.
9. 9. Gment G, Matejka M, Porteder H, Sinzinger H. Indium 111-A - bleomycin - a new tracer for imaging orofacial neoplasms. J Oral Maxillofac Surg 1988, 46, 742-745.
10. 10. Hiltunen JV, Kairemo KJA, Nikula TK. Pharmacokinetic properties of low pH In-111-bleomycin complex. In: Maddalena DJ, Snowdon GM, Boniface GR, eds. Advances in Radiopharmacology. Proceedings of the Sixth International Symposium on Radiopharmacology, International Association of Radiopharmacology, Wollongong University Press, Australia, 1990, 136-139.
11. 11. Kairemo KJA, Ramsay H, Hiltunen JV, et al. Imaging of head and neck carcinomas with low pH 111In-bleomycin complex. Aust NZ J Med 1990, 20, 448.
12. 12. Watkinson JC, Lazarus CR, Mistry R, Shaheen OH, Maisey MN, Clarke SE. Technetium-99m(V) dimercaptosuccinin acid uptake in patients with head and neck squamous carcinoma: experience in imaging. J Nucl Med 1989, 30, 174-180.
13. 13. Cummings CW, Larson SM, Dobie RA, Weymuller EA Jr, Rudd TG, Merello A. Assessment of cobalt-57 tagged bleomycin as a clinical aid in staging head and neck carcinoma. Laryngoscope 1981, 91, 529-537.
14. 14. Higashi T, Kashima I, Shimura K, et al. Gallium-67 scanning in the evaluation of therapy of malignant tumors of the head and neck. J Nucl Med 1977, 18, 243-249.
15. 15. Teates CD, Preston DF, Boyd CM. Gallium-67 citrate imaging in head and neck tumors: report of co-operative group. J Nucl Med 1980, 21, 622-627.
16. 16. Goode R, Goodwin D, Burget P, Nelson L. Radioisotope scanning for tumors of the head and neck - experience with indium-111 and phosphorus-32. Arch Otolaryngol 1973, 97, 313-315.
17. 17. Kairemo KJA, Hopsu EVM. Diagnosis of tumors of the parotid gland with anti-CEA immunoscintigraphy. Am J Roentgenol 1990, 154, 1259-1262.
18. 18. Kairemo KJA, Hopsu EVM. Imaging of pharyngeal and laryngeal carcinomas with indium-111-labeled monoclonal anti-CEA antibodies. Laryngoscope 1990, 100, 1077-1082.
19. 19. Baum RP, Adams S, Kiefer J, et al. A novel Tc-99m labeled monoclonal antibody (174 H.64) for staging head and neck cancer by immuno-SPECT. Acta Oncol 1993, 32, 747-751.
20. 20. Soo KC, Ward M, Roberts KR, et al. Radioimmuno-32#scintigraphy of squamous carcinomas of the head and neck. Head Neck Surg 1987, 9, 349-352.
21. 21. Van Dongen GAMS, Leverstein H, Roos JC, et al. Radioimmunoscintigraphy of head and neck tumors using 99mTc-labeled monoclonal antibody E48 F(ab′)2. Cancer Res 1992, 52, 2569-2574.
22. 22. Schrijvers AHGJ, Quak JJ, Uyterlinde AM, et al. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck. Cancer Res 1993, 53, 3524-3529.
23. 23. De Bree R, Roos JC, Quak JJ, et al. Clinical imaging of head and neck cancer with 99mTc-labeled monoclonal antibody E48 IgG or F(ab′)2. J Nucl Med 1994, 35, 775-783.
24. 24. Snyder WS, Fisher HL Jr, Ford MR, Warner GG. Estimates of absorbed fractions for monoenergetic photo sources uniformly distributed in various organs of a heterogenous phantom: MIRD Pamphlet no. 5. J Nucl Med 1969, 10 (Suppl. 3), 7-52.
25. 25. Stabin M. MIRDOSE 3, Radiation International Dose Information Center, Institute for Science and Education, USA.
26. 26. Kairemo KJA, Ramsay HA, Paavonen T, et al. Dosimetric and biokinetic aspects of indium-111-bleomycin complex in head and neck cancer - implementations for radiochemotherapy. Cancer Detect Prevent, in press.
27. 27. Pohjonen H, Nikkinen P, Sipila O, et al. Registration and display of brain SPECT and MRI using external markers. Neuroradiology, 1996, 38, 108-114.
28. 28. Shanta V, Krishnamurti S, Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 1980, 31, 617-620.
29. 29. Fu KK, Phillilps T, Silverberg T, et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer. J Clin Oncol 1987, 5, 1410-1418.
30. 30. Vermund H, Kaalhus O, Winther F, et al. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aerodigestive tract: a phase III clinical trial. lnt J Radiat Oncol Biol Phys 1985, 11, 1877-1886.
31. 31. Eisenberger M, Jacobs M. Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of the head and neck. Semin Oncol 1992, 19 (suppl. 11), 41-46.
32. 32. Howell RW, Narra VR, Sastry KSR, Rao DV. On the equivalent dose for Auger electron emitters. Radiation Res 1993, 134, 71-78.
33. 33. Narra VR, Sastry KSR, Goddu SM, Howell RW, Strand S-E, Roa DV. The relative biological effectiveness of 99mTc radiopharmaceuticals. Med Phys 1994, 21, 1921-1926.
34. 34. Fujimoto J. Radioautoradiographic studies on the intracellular distribution of 14C-bleomycin in mouse tumor cells. Cancer Res 1974, 34, 2969-2974.
35. 35. Dorr RT. Bleomycin pharmacology: mechanisms of action and resistance, and clinical pharmacokinetics. Semin Oncol 1992 (suppl 5), 3-8.
36. 36. Hou DY, Maruyama Y. Distribution of 111In-bleomycin complex in small cell lung cancer cells by autoradiography. J Surg Oncol 1992, 49, 93-97.
37. 37. Kasai H, Naganawa H, Takita T, et al. Chemistry of bleomycin. XXII. Interaction of bleomycin with nucleic acids, preferential binding to guanine base and electrostatic effect of the terminal amine. J Antibiot (A) 1978, 31, 1316-1320.
38. 38. Barranco SC, Novak JK, Humphrey RM. Response of mammalian cells following treatment with bleomycin and 1,3-bis(2-chloroethyl)1-nitrosourea during plateau phase. Cancer Res 1973, 33, 691-694.
39. 39. Barlogie B, Drewinko B, Schumann J, et al. Pulse cytometric analysis of cell cycle perturbation with bleomycin in vitro. Cancer Res 1976, 36, 1182-1187.
40. 40. Hou DY, Maruyama Y, Drago JR. Chromosome aberrations of human small cell lung cancer induced by a new 111In-bleomycin complex. J Surg Oncol 1992, 51, 236-242.
41. 41. Kuwahara J, Sugiura Y. Sequence-specific recognition with cleavage of DNA by metallomycin: minor groove binding and possible interaction mode. Proc Natl Acad Sci USA 1988, 85, 2459-2463.
42. 42. Kakinuma J, Orii H. DNA interaction with 57Co bleomycin. Nuklearmedizin 1982, 21, 232-235.
43. 43. Sgouros G. Bone marrow dosimetry for radioimmunotherapy: theoretical considerations. J Nucl Med 1993, 34, 689-694.